Kadant (KAI) Director Sells 415 Shares at $338.41
Insider transaction: Kadant Inc. director Leonard Thomas C reported a sale of 415 shares of Kadant common stock on 08/27/2025 at a reported price of $338.4138 per share.
Rhea-AI Filing Summary
Insider transaction: Kadant Inc. director Leonard Thomas C reported a sale of 415 shares of Kadant common stock on 08/27/2025 at a reported price of $338.4138 per share. After the transaction he beneficially owned 4,250 shares directly. The Form 4 was signed under power of attorney.
Positive
- Transparency: Transaction disclosed on Form 4 showing price, quantity, and resulting ownership
- No derivative activity: Table II is empty, indicating no options or convertible securities were reported
Negative
- Director sale: Director disposed of 415 shares, which may be viewed unfavorably by some investors
- Limited context: Filing does not state whether sale was pursuant to a Rule 10b5-1 plan
Insights
TL;DR: A director executed a small, single stock sale leaving a modest remaining stake of 4,250 shares.
The reported sale of 415 shares at $338.4138 reduces the reporting person’s direct holding to 4,250 shares. The transaction is a simple open-market disposition and does not disclose any derivative activity or additional purchases. On its face, this is routine insider selling and provides limited new information about company operations or financials.
TL;DR: Routine director sale; no indications of plan-based trades or related-party transactions disclosed.
The Form 4 identifies the reporting person as a director and shows a direct sale. There is no accompanying notation of a Rule 10b5-1 plan or indirect beneficial ownership changes. Governance signals are neutral: an isolated sale without additional context is common and not, by itself, a material governance event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 415 | $338.4138 | $140K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 4 reporting Kadant (KAI) insider activity?
What transaction was reported for KAI on this Form 4?
Did the Form 4 disclose any derivative securities or option exercises for KAI?
Was the Form 4 filed jointly or by one reporting person for KAI?
AI-generated analysis. How Rhea-AI works. Not financial advice.